Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy

房颤患者术后延迟抗凝治疗后发生急性肾动脉血栓形成:支持阿哌沙班单药治疗的病例报告

阅读:2

Abstract

Renal artery thrombosis is a rare but potentially devastating vascular emergency, often misdiagnosed due to its nonspecific symptoms. Atrial fibrillation (AF) is a well-known cause of systemic thromboembolism, yet embolisation to the renal arteries remains uncommon. Timely recognition and appropriate anticoagulation are essential to minimise irreversible renal injury. We report the case of an 84-year-old woman with a history of AF (CHA2DS2-VASc score of 5) who developed acute unilateral renal artery thrombosis shortly after undergoing a unilateral mastectomy with sentinel lymph node biopsy. Anticoagulation with apixaban had been appropriately held preoperatively due to bleeding risk, but its resumption was delayed until five days postoperatively. The patient presented with acute flank pain, hypertension, and an acute kidney injury on postoperative day five. A CT abdomen pelvis confirmed a left renal artery thrombosis. Remarkably, a CT angiogram of the whole aorta, performed within 24 hours of restarting apixaban, showed resolution of the thrombus, although renal function did not improve by discharge. This case contributes to the limited but growing body of literature suggesting that direct oral anticoagulant (DOAC) monotherapy, specifically apixaban, is effective in managing renal artery thrombosis. It also reinforces the need for clinicians to consider the timely resumption of anticoagulation and to carefully reassess perioperative management in high-risk AF patients to prevent irreversible thromboembolic complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。